Actos Lawsuit

Tweet

New research has added to the growing body of evidence linking Actos to increased adverse health risks including bladder cancer.

Actos Update 4/27/12: The Canadian province of Ontario is limiting patient access to Actos due to the risk of bladder cancer that has become increasingly linked to the drug. The Ontario Public Drug (OPD) program has announced that it is removing Actos from its list of approved drugs, which means that in the future patients will need to go through special steps in order to obtain the medication. Click here to learn more.

Actos Bladder Cancer Update 4/24/12: Last week, Health Canada announced that it was requiring new bladder cancer warnings to be added to labels of Actos. The move came following a safety review of the drug that was launched last year, when the U.S. Food & Drug Administration (FDA) required similar warnings for Actos in this country. Click here to learn more.

Actos Bladder Cancer Update: December 31, 2011: According to a judicial panel, lawsuits involving Takeda’s blockbuster diabetes drug Actos (pioglitazone) will be centralized before one judge in Louisiana federal court. The complaints allege that patients who use Actos are at an increased risk of developing bladder cancer, and that Takeda knowingly withheld information about this risk and failed to provide adequate warnings. Click here to learn more.

Actos Macular Edema Update: June 27, 2011: British researchers have announced new information indicating that Actos may increase the risk of macular edema in diabetics who fail to keep their blood sugar under control.The research also implicated Avandia, a similar drug in the same class that has been under heavy scrutiny due to concerns about an increased risk of heart attacks and death in certain users. Click here to learn more.

Actos Bladder Cancer Update: June 15, 2011: The FDA has required that new information about an increased risk of bladder cancer be added to the Warnings and Precautions section of Actos labels. The enhanced warning was prompted after the administration’s review of a study that found an increased risk of bladder cancer in patients taking Actos at high doses for an extended period of time. Read more here.

Free Actos Side Effects Case Evaluation: If you or a loved one has suffered from bladder cancer, macular edema, heart problems or other serious side effects after taking Actos, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

Actos (pioglitazone hydrochloride) Side Effects

Actos is an oral medication which is used for treatment of Type 2 diabetes. It is part of the same class of drugs as Avandia (rosiglitazone), which has been the focus of concern in the medical community since reports found that Avandia may increase the risk of heart attacks and heart related death.

Actos side effects include (but are not limited to):

• congestive heart failure (CHF)
• heart attack
• stroke
• liver problems
• fractures
• bladder cancer
• macular edema

The link between Actos and heart failure is strong enough that in 2007 the FDA increased the warnings on the drug concerning congestive heart failure.

Do I have an Actos Lawsuit?

The Defective Drug & Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Actos side effects lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.

If you or a loved one has suffered from bladder cancer, macular edema, heart problems or other serious side effects after taking Actos, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.